Item 1. Financial Statements
Item 1. Financial Statements
FORMFACTOR, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except share and per share amounts)
(Unaudited)
March 29,
2025 December 28,
2024
ASSETS
Current assets:
Cash and cash equivalents $ 129,889 $ 190,728
Marketable securities 169,099 169,295
Accounts receivable, net of allowance for credit losses of $ 12 and $ 4
98,605 104,294
Inventories, net 109,965 101,676
Restricted cash 967 3,746
Prepaid expenses and other current assets 42,716 35,389
Total current assets 551,241 605,128
Restricted cash 2,445 2,732
Operating lease, right-of-use-assets 20,054 22,579
Property, plant and equipment, net of accumulated depreciation 208,317 210,230
Equity investment 68,667 —
Goodwill 199,700 199,171
Intangibles, net 9,681 10,355
Deferred tax assets 92,759 92,012
Other assets 3,303 4,008
Total assets $ 1,156,167 $ 1,146,215
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable $ 64,536 $ 62,287
Accrued liabilities 34,909 43,742
Current portion of term loan, net of unamortized issuance costs 1,113 1,106
Deferred revenue 14,996 15,847
Operating lease liabilities 8,461 8,363
Total current liabilities 124,015 131,345
Term loan, less current portion, net of unamortized issuance costs 11,927 12,208
Long-term operating lease liabilities 15,980 17,550
Deferred grant 18,000 18,000
Other liabilities 20,371 19,344
Total liabilities 190,293 198,447
Stockholders’ equity:
Common stock, $ 0.001 par value:
250,000,000 shares authorized; 77,075,636 and 77,114,633 shares issued and outstanding
77 77
Additional paid-in capital 844,488 837,586
Accumulated other comprehensive loss ( 6,037 ) ( 10,840 )
Accumulated income 127,346 120,945
Total stockholders’ equity 965,874 947,768
Total liabilities and stockholders’ equity $ 1,156,167 $ 1,146,215
The accompanying notes are an integral part of these condensed consolidated financial statements.
3
FORMFACTOR, INC.
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(In thousands, except per share amounts)
(Unaudited)
Three Months Ended
March 29,
2025 March 30,
2024
Revenues $ 171,356 $ 168,725
Cost of revenues 106,833 105,987
Gross profit 64,523 62,738
Operating expenses:
Research and development 27,800 28,627
Selling, general and administrative 33,454 33,079
Total operating expenses 61,254 61,706
Gain on sale of business — 20,271
Operating income
3,269 21,303
Interest income, net 3,317 3,156
Other income, net
890 520
Income before income taxes 7,476 24,979
Provision for income taxes
1,075 3,198
Net income $ 6,401 $ 21,781
Net income per share:
Basic $ 0.08 $ 0.28
Diluted $ 0.08 $ 0.28
Weighted-average number of shares used in per share calculations:
Basic 77,345 77,452
Diluted 77,884 78,490
The accompanying notes are an integral part of these condensed consolidated financial statements.
4
FORMFACTOR, INC.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(In thousands)
(Unaudited)
Three Months Ended
March 29,
2025 March 30,
2024
Net income $ 6,401 $ 21,781
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustments 3,339 ( 2,283 )
Unrealized gains (losses) on available-for-sale marketable securities 370 ( 198 )
Unrealized gains (losses) on derivative instruments 1,094 ( 232 )
Other comprehensive income (loss), net of tax: 4,803 ( 2,713 )
Comprehensive income $ 11,204 $ 19,068
The accompanying notes are an integral part of these condensed consolidated financial statements.
5
FORMFACTOR, INC.
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
(In thousands, except shares)
(Unaudited)
Shares of
Common
Stock Common
Stock Additional
Paid-in
Capital Accumulated
Other
Comprehensive
Loss Accumulated
Income
Total
Three Months Ended March 29, 2025
Balances, December 28, 2024
77,114,633 $ 77 $ 837,586 $ ( 10,840 ) $ 120,945 $ 947,768
Issuance of common stock under the Employee Stock Purchase Plan 197,051 — 6,576 — — 6,576
Issuance of common stock pursuant to vesting of restricted stock units, net of stock withheld for tax 93,981 — ( 2,132 ) — — ( 2,132 )
Issuance of common stock pursuant to private placement 334,971 — 15,000 — — 15,000
Purchase and retirement of common stock through repurchase program ( 665,000 ) — ( 22,207 ) — — ( 22,207 )
Stock-based compensation — — 9,665 — — 9,665
Other comprehensive income — — — 4,803 — 4,803
Net income — — — — 6,401 6,401
Balances, March 29, 2025
77,075,636 $ 77 $ 844,488 $ ( 6,037 ) $ 127,346 $ 965,874
Three Months Ended March 30, 2024
Balances, December 30, 2023 77,376,903 $ 77 $ 861,448 $ ( 4,052 ) $ 51,331 $ 908,804
Issuance of common stock under the Employee Stock Purchase Plan 197,014 — 4,948 — — 4,948
Issuance of common stock pursuant to vesting of restricted stock units, net of stock withheld for tax 78,957 — ( 1,840 ) — — ( 1,840 )
Purchase and retirement of common stock through repurchase program ( 411,756 ) — ( 17,398 ) — — ( 17,398 )
Stock-based compensation — — 10,168 — — 10,168
Other comprehensive loss — — — ( 2,713 ) — ( 2,713 )
Net income — — — — 21,781 21,781
Balances, March 30, 2024
77,241,118 $ 77 $ 857,326 $ ( 6,765 ) $ 73,112 $ 923,750
The accompanying notes are an integral part of these condensed consolidated financial statements.
6
FORMFACTOR, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)
Three Months Ended
March 29,
2025 March 30,
2024
Cash flows from operating activities:
Net income $ 6,401 $ 21,781
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation 8,156 7,193
Amortization 674 640
Reduction in the carrying amount of right-of-use assets 1,803 1,415
Stock-based compensation expense 9,796 10,405
Deferred income tax benefit ( 691 ) ( 1,293 )
Provision for excess and obsolete inventories 2,879 3,146
Non-cash restructuring charges 2,102 —
Gain on sale of business — ( 20,271 )
Other adjustments to reconcile net income to net cash provided by operating activities ( 1,024 ) 176
Changes in assets and liabilities:
Accounts receivable 6,293 6,466
Inventories ( 10,196 ) ( 4,926 )
Prepaid expenses and other current assets ( 3,794 ) 1,224
Other assets 469 17
Accounts payable 10,535 4,948
Accrued liabilities ( 7,926 ) ( 1,963 )
Other liabilities 712 1,085
Deferred revenues ( 620 ) 4,499
Operating lease liabilities ( 2,030 ) ( 1,530 )
Net cash provided by operating activities 23,539 33,012
Cash flows from investing activities:
Acquisition of property, plant and equipment ( 18,584 ) ( 13,436 )
Proceeds from sale of business — 21,275
Purchase of equity investment ( 67,156 ) —
Purchases of marketable securities ( 26,330 ) ( 37,472 )
Proceeds from maturities and sales of marketable securities 27,410 25,813
Net cash used in investing activities ( 84,660 ) ( 3,820 )
Cash flows from financing activities:
Proceeds from issuances of common stock 21,576 4,948
Purchase of common stock through stock repurchase program ( 22,135 ) ( 17,334 )
Tax withholdings related to net share settlements of equity awards ( 2,132 ) ( 1,840 )
Payments on term loan ( 273 ) ( 266 )
Net cash used in financing activities ( 2,964 ) ( 14,492 )
Effect of exchange rate changes on cash, cash equivalents and restricted cash 180 ( 1,592 )
Net increase (decrease) in cash, cash equivalents and restricted cash ( 63,905 ) 13,108
Cash, cash equivalents and restricted cash, beginning of year 197,206 181,273
Cash, cash equivalents and restricted cash, end of period $ 133,301 $ 194,381
The accompanying notes are an integral part of these condensed consolidated financial statements.
7
FORMFACTOR, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)
Three Months Ended
March 29,
2025 March 30,
2024
Non-cash investing and financing activities:
Decrease in accounts payable and accrued liabilities related to property, plant and equipment purchases $ 8,563 $ 2,567
Supplemental disclosure of cash flow information:
Cash paid for income taxes, net $ 1,826 $ 1,423
Cash paid for interest 92 100
Operating cash outflows from operating leases 2,414 2,305
Reconciliation of cash, cash equivalents and restricted cash:
Cash and cash equivalents $ 129,889 $ 186,296
Restricted cash, current 967 5,865
Restricted cash 2,445 2,220
Total cash, cash equivalents and restricted cash $ 133,301 $ 194,381
The accompanying notes are an integral part of these condensed consolidated financial statements.
8
FORMFACTOR, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Note 1 — Basis of Presentation and Significant Accounting Policies
Basis of Presentation
The accompanying condensed consolidated financial information of FormFactor, Inc. is unaudited and has been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). However, such information reflects all adjustments, consisting only of normal recurring adjustments, which are, in the opinion of management, necessary for a fair presentation of the financial position, results of operations and cash flows for the interim periods. The condensed consolidated financial statements included herein should be read in conjunction with the consolidated financial statements and the notes thereto included in our 2024 Annual Report on Form 10-K filed with the SEC on February 21, 2025. The results of operations for the interim periods presented are not necessarily indicative of the results to be expected for the full year.
Fiscal Year
We operate on a 52/53 week fiscal year, whereby the fiscal year ends on the last Saturday of December. Fiscal 2025 and 2024 each contain 52 weeks and the three months ended March 29, 2025 and March 30, 2024 each contained 13 weeks. Fiscal 2025 will end on December 27 , 2025.
Significant Accounting Policies
Our significant accounting policies have not changed during the three months ended March 29, 2025 from those disclosed in our Annual Report on Form 10-K for the year ended December 28, 2024, except for:
Equity Investment
On February 21, 2025, Frontier Investments Co., Ltd (“HoldCo”), a joint holding company in which we hold a 20 % share of the equity and an affiliate of MBK Partners holds an 80 % share of the equity, through HoldCo’s wholly-owned subsidiary, FM Holdings Co., Ltd., acquired 100 % of the shares of FICT Limited (“FICT”) from Advantage Partners Inc. Our investment of $ 67.2 million, comprises the funding of our share of the purchase price of $ 59.6 million, subject to changes in foreign currency fluctuations, and acquisition costs of $ 7.5 million. Headquartered in Nagano, Japan, FICT is a provider of semiconductor test and high-performance computing industries with complex multi-layer organic substrates, printed circuit boards, and related leading-edge technologies and services.
This investment is accounted for as an equity method investment and recorded in Equity investment on our Condensed Consolidated Balance Sheets.
We will report the results of our share of the investment with HoldCo on a one-quarter lag as their results are not expected to be available in time to be recorded in the concurrent period.
During the three months ended March 29, 2025, we engaged in transactions with FICT, a related party. These transactions were conducted in the normal course of business and at arm's length. The total amount of these transactions was not material to our financial statements.
New Accounting Pronouncements
ASU 2024-03
In November 2024, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) No. 2024-03, “ Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses .” This ASU requires an entity to disclose the amounts of purchases of inventory, employee compensation, depreciation, and intangible asset amortization included in each relevant expense caption. It also requires an entity to include certain amounts that are already required to be disclosed under current GAAP in the same disclosure. Additionally, it requires an entity to disclose a qualitative description of the amounts remaining in relevant expense captions that are not separately disaggregated quantitatively, and to disclose the total amount of selling expenses and, in annual reporting periods, an entity’s definition of selling expenses. The amendments in the ASU are effective for annual reporting periods beginning after December 15, 2026 and interim reporting periods beginning after December 15, 2027, with early adoption permitted. An entity may apply the amendments prospectively for reporting periods after the effective date or retrospectively to any or all prior periods presented in the financial statements. While this ASU will impact only our disclosures
9
and not our financial condition and results of operations, we are currently evaluating the effect the adoption of this ASU may have on our disclosures.
ASU 2023-09
In December 2023, the FASB issued ASU 2023-09, “ Income Taxes (Topic 740): Improvements to Income Tax Disclosures. ” The ASU includes requirements that an entity disclose specific categories in the rate reconciliation and provide additional information for reconciling items that are greater than five percent of the amount computed by multiplying pretax income by the applicable statutory income tax rate. The standard also requires that entities disclose income before income taxes and provision for income taxes disaggregated between domestic and foreign. This ASU is effective for annual periods beginning after December 15, 2024, with early adoption permitted. An entity may apply the amendments outlined in this ASU prospectively by providing the revised disclosures for the current period and continuing to provide the pre-ASU disclosures for the prior periods, or may apply the amendments retrospectively by providing the revised disclosures for all periods presented. We will adopt this ASU retrospectively for the period ending December 27, 2025, and it will impact only our disclosures with no impacts to our financial condition and results of operations.
Note 2 — Concentration of Credit and Other Risks
Each of the following customers accounted for 10 % or more of our revenues for the periods indicated:
Three Months Ended
March 29,
2025 March 30,
2024
SK hynix Inc. 23.3 % 15.5 %
Intel Corporation 12.0 % 15.7 %
Samsung Electronics Co., LTD. * 12.4 %
35.3 % 43.6 %
* Less than 10% of revenues.
At March 29, 2025 and December 28, 2024, three customers accounted for 16.5 %, 15.8 %, and 12.4 % and one customer accounted for 22.0 % of gross accounts receivable, respectively.
Note 3 — Inventories, net
Inventories are stated at the lower of cost (principally standard cost, which approximates actual cost on a first in, first out basis) or net realizable value.
Inventories, net, consisted of the following (in thousands):
March 29,
2025 December 28,
2024
Raw materials $ 46,873 $ 45,547
Work-in-progress 42,526 38,366
Finished goods 20,566 17,763
$ 109,965 $ 101,676
Note 4 — Divestiture
On February 7, 2024, we entered into a definitive agreement to sell our China operations to Grand Junction Semiconductor Pte. Ltd. (“Grand Junction”) for $ 25.0 million in cash, subject to customary purchase price adjustments, and establish an exclusive distribution and partnership agreement to continue sales and support of our products in the region. The following subsidiaries were included as part of the divestiture: Microprobe Hong Kong Limited, FormFactor Technology (Suzhou) Co. Ltd., Cascade Microtech Singapore Pte, Ltd, and FormFactor International (Shanghai) Trading Co., Ltd. These entities supported both the Probe Cards and Systems segments.
On February 26, 2024, we closed on the sale of the operations in China to Grand Junction and received total consideration of $ 21.4 million, net of cash transferred and transaction expenses, and after customary adjustments for indebtedness and changes in net working capital. The disposition of the China operations did not meet the criteria to be classified as a discontinued operation in our financial statements because the disposition did not represent a strategic shift that had, or will have, a major effect on our operations and financial results.
10
The following table summarizes the fair value of the sale proceeds received in connection with the divestiture (in thousands):
February 26, 2024
Gross purchase price $ 25,000
Working capital adjustment
159
Cash transferred to the buyer at closing ( 2,743 )
Direct costs to sell ( 986 )
Fair value of sale consideration, net $ 21,430
The carrying amount of net assets associated with the China operations was approximately $ 1.2 million. The major classes of assets and liabilities sold consisted of the following (in thousands):
February 26, 2024
ASSETS
Accounts receivable, net $ 1,174
Inventories, net 3,729
Other current assets 391
Total current assets 5,294
Property, plant and equipment, net 1,283
Goodwill 1,117
Other assets 3,029
Total assets $ 10,723
LIABILITIES
Deferred revenue $ 3,739
Other current liabilities 1,546
Other liabilities 4,283
Total liabilities $ 9,568
As a result of the divestiture, we recognized a pre-tax gain of $ 20.3 million. We recorded income tax expense associated with the divestiture of approximately $ 3.3 million.
Note 5 — Goodwill and Intangible Assets
Goodwill by reportable segment was as follows (in thousands):
Probe Cards Systems Total
Goodwill, as of December 30, 2023 $ 178,424 $ 22,666 $ 201,090
Reduction - China divestiture ( 1,055 ) ( 62 ) ( 1,117 )
Foreign currency translation — ( 802 ) ( 802 )
Goodwill, as of December 28, 2024
177,369 21,802 199,171
Foreign currency translation — 529 529
Goodwill, as of March 29, 2025
$ 177,369 $ 22,331 $ 199,700
We have no t recorded goodwill impairments for the three months ended March 29, 2025.
11
Intangible assets were as follows (in thousands):
March 29, 2025 December 28, 2024
Intangible Assets Gross Accumulated
Amortization Net Gross Accumulated
Amortization Net
Existing developed technologies $ 159,778 $ 150,531 $ 9,247 $ 159,360 $ 149,631 $ 9,729
Trade name 7,784 7,759 25 7,736 7,700 36
Customer relationships 47,956 47,547 409 47,831 47,241 590
$ 215,518 $ 205,837 $ 9,681 $ 214,927 $ 204,572 $ 10,355
Amortization expense was included in our Condensed Consolidated Statements of Income as follows (in thousands):
Three Months Ended
March 29,
2025 March 30,
2024
Cost of revenues $ 483 $ 449
Selling, general and administrative 191 191
$ 674 $ 640
The estimated future amortization of definite-lived intangible assets, excluding in-process research and development, is as follows (in thousands):
Fiscal Year Amount
Remainder of 2025
$ 1,790
2026 1,763
2027 1,741
2028 1,630
2029 1,630
Thereafter 1,127
$ 9,681
Note 6 — Accrued Liabilities
Accrued liabilities consisted of the following (in thousands):
March 29,
2025 December 28,
2024
Accrued compensation and benefits $ 22,149 $ 26,077
Accrued warranty 3,551 3,558
Accrued income and other taxes 1,828 2,969
Accrued employee stock purchase plan contributions withheld 2,205 6,034
Other accrued expenses 5,176 5,104
$ 34,909 $ 43,742
Note 7 — Fair Value and Derivative Instruments
Whenever possible, the fair values of our financial assets and liabilities are determined using quoted market prices of identical securities or quoted market prices of similar securities from active markets. The three levels of inputs that may be used to measure fair value are as follows:
• Level 1 valuations are obtained from real-time quotes for transactions in active exchange markets involving identical securities;
• Level 2 valuations utilize significant observable inputs, such as quoted prices for similar assets or liabilities, quoted prices near the reporting date in markets that are less active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and
• Level 3 valuations utilize unobservable inputs to the valuation methodology and include our own data about assumptions market participants would use in pricing the asset or liability based on the best information available under the circumstances.
12
We did not have any transfers of assets or liabilities measured at fair value on a recurring basis to or from Level 1, Level 2 or Level 3 during the three months ended March 29, 2025 or the year ended December 28, 2024.
The carrying values of Cash, Accounts receivable, net, Restricted cash, Prepaid expenses and other current assets, Accounts payable, and Accrued liabilities approximate fair value due to their short maturities.
No changes were made to our valuation techniques during the first three months of fiscal 2025.
Assets and Liabilities Measured at Fair Value on a Recurring Basis
Assets and liabilities measured at fair value on a recurring basis were as follows (in thousands):
March 29, 2025 Level 1 Level 2 Level 3 Total
Assets:
Cash equivalents:
Money market funds $ 65,074 $ — $ — $ 65,074
U.S. treasuries 1,598 — — 1,598
Commercial paper — 999 — 999
66,672 999 — 67,671
Marketable securities:
U.S. treasuries 66,517 — — 66,517
U.S. agency securities — 15,180 — 15,180
Corporate bonds — 81,511 — 81,511
Commercial paper — 5,891 — 5,891
66,517 102,582 — 169,099
Foreign exchange derivative contracts — 280 — 280
Promissory note receivable — — 1,516 1,516
Interest rate swap derivative contracts — 1,740 — 1,740
Total assets $ 133,189 $ 105,601 $ 1,516 $ 240,306
Liabilities:
Foreign exchange derivative contracts $ — $ ( 42 ) $ — $ ( 42 )
Total liabilities $ — $ ( 42 ) $ — $ ( 42 )
December 28, 2024 Level 1 Level 2 Level 3 Total
Assets:
Cash equivalents:
Money market funds $ 131,519 $ — $ — $ 131,519
Marketable securities:
U.S. treasuries 71,252 — — 71,252
U.S. agency securities — 13,869 — 13,869
Corporate bonds — 83,176 — 83,176
Commercial paper — 998 — 998
71,252 98,043 — 169,295
Promissory note receivable — — 1,512 1,512
Interest rate swap derivative contracts — 2,025 — 2,025
Total assets $ 202,771 $ 100,068 $ 1,512 $ 304,351
Liabilities:
Foreign exchange derivative contracts $ — $ ( 1,141 ) $ — $ ( 1,141 )
Total liabilities $ — $ ( 1,141 ) $ — $ ( 1,141 )
13
Cash Equivalents
The fair value of our cash equivalents is determined based on quoted market prices for similar or identical securities.
Marketable Securities
We classify our marketable securities as available-for-sale and value them utilizing a market approach. Our investments are priced by pricing vendors who provide observable inputs for their pricing without applying significant judgment. Broker pricing is used mainly when a quoted price is not available, the investment is not priced by our pricing vendors or when a broker price is more reflective of fair value. Our broker-priced investments are categorized as Level 2 investments because fair value is based on similar assets without applying significant judgments. In addition, all investments have a sufficient trading volume to demonstrate that the fair value is appropriate.
Unrealized gains and losses were immaterial and were recorded as a component of Accumulated other comprehensive loss in our Condensed Consolidated Balance Sheets. We did not have any other-than-temporary unrealized gains or losses at either period end included in these financial statements.
Interest Rate Swap
The fair value of our interest rate swap contract is determined at the end of each reporting period based on valuation models that use interest rate yield curves as inputs. For accounting purposes, our interest rate swap contract qualifies for, and is designated as a cash flow hedge. The hedged risk is the interest rate exposure to changes in interest payments attributable to changes in our variable-rate interest over the interest rate swap term. The changes in cash flows of the interest rate swap are expected to exactly offset changes in cash flows of the variable-rate debt. Cash settlements, in the form of cash payments or cash receipts, are recognized as a component of interest expense. The cash flows associated with the interest rate swaps are reported in Net cash provided by operating activities in our Condensed Consolidated Statements of Cash Flows and the fair value of the interest rate swap contracts are recorded within Prepaid expenses and other current assets and Other assets in our Condensed Consolidated Balance Sheets.
Foreign Exchange Derivative Contracts
We operate and sell our products in various global markets. As a result, we are exposed to changes in foreign currency exchange rates. We utilize foreign currency forward contracts to hedge against future movements in foreign exchange rates that affect certain existing foreign currency denominated assets and liabilities and forecasted foreign currency revenue and expense transactions. Under this program, our strategy is to have increases or decreases in our foreign currency exposures mitigated by gains or losses on the foreign currency forward contracts in order to mitigate the risks and volatility associated with foreign currency transaction gains or losses.
We do not use derivative financial instruments for speculative or trading purposes. For accounting purposes, certain of our foreign currency forward contracts are not designated as hedging instruments and, accordingly, we record the fair value of these contracts as of the end of our reporting period in our Condensed Consolidated Balance Sheets with changes in fair value recorded within Other income, net in our Condensed Consolidated Statement of Income for both realized and unrealized gains and losses. Certain of our foreign currency forward contracts are designated as cash flow hedges, and, accordingly, we record the fair value of these contracts as of the end of our reporting period in our Condensed Consolidated Balance Sheets with changes in fair value recorded as a component of Accumulated other comprehensive loss and reclassified into earnings in the same period in which the hedged transaction affects earnings, and in the same line item on the Condensed Consolidated Statements of Income as the impact of the hedge transaction.
The fair value of our foreign exchange derivative contracts was determined based on current foreign currency exchange rates and forward points. All of our foreign exchange derivative contracts outstanding at March 29, 2025 will mature by the first quarter of fiscal 2026.
The following table provides information about our foreign currency forward contracts outstanding as of March 29, 2025 (in thousands):
Currency Contract Position Contract Amount
(Local Currency) Contract Amount
(U.S. Dollars)
Euro Buy 31,412 $ 34,001
Japanese Yen Sell 1,236,544 8,265
Korean Won Buy 2,140,919 1,463
Taiwan Dollar Sell 117,600 3,549
14
Our foreign currency contracts are classified within Level 2 of the fair value hierarchy as they are valued using pricing models that utilize observable market inputs.
Assets and Liabilities Measured at Fair Value on a Non-Recurring Basis
We measure and report our non-financial assets such as Property, plant and equipment, Equity investment, Goodwill and Intangible assets at fair value on a non-recurring basis if we determine these assets to be impaired or in the period when we make a business acquisition. There were no assets or liabilities measured at fair value on a nonrecurring basis during the three months ended March 29, 2025 or March 30, 2024.
Note 8 — Warranty
We offer warranties on certain products and record a liability for the estimated future costs associated with warranty claims at the time revenue is recognized. The warranty liability is based upon historical experience and our estimate of the level of future costs. While we engage in product quality programs and processes, our warranty obligation is affected by product failure rates, material usage and service delivery costs. We regularly monitor product returns for warranty and maintain a reserve for the related expenses based upon our historical experience and any specifically identified failures. As we sell new products to our customers, we must exercise considerable judgment in estimating the expected failure rates. This estimating process is based on historical experience of similar products, as well as various other assumptions that we believe to be reasonable under the circumstances. We provide for the estimated cost of product warranties at the time revenue is recognized as a component of Cost of revenues in our Condensed Consolidated Statement of Income.
Changes in our warranty liability were as follows (in thousands):
Three Months Ended
March 29,
2025 March 30,
2024
Balance at beginning of year $ 3,558 $ 3,177
Accruals 1,668 2,729
Settlements ( 1,675 ) ( 2,238 )
Balance at end of period $ 3,551 $ 3,668
Note 9 — Property, Plant and Equipment, net
Property, plant and equipment, net consisted of the following (in thousands):
March 29,
2025 December 28,
2024
Land $ 17,124 $ 17,124
Building and building improvements 46,484 46,578
Machinery and equipment 316,614 307,201
Computer equipment and software 48,241 47,344
Furniture and fixtures 7,522 7,430
Leasehold improvements 102,588 101,374
Sub-total 538,573 527,051
Less: Accumulated depreciation and amortization ( 387,142 ) ( 379,968 )
Net property, plant and equipment 151,431 147,083
Construction-in-progress 56,886 63,147
Total $ 208,317 $ 210,230
Note 10 — Stockholders’ Equity and Stock-Based Compensation
Common Stock Repurchase Programs
On October 30, 2023, our Board of Directors authorized a two-year program to repurchase up to $ 75.0 million of outstanding common stock, with the primary purpose of offsetting potential dilution from issuance of common stock under our stock-based compensation programs. On March 29, 2025, our Board of Directors approved an increase to the repurchase program, authorizing the repurchase of an additional $ 1.6 million in shares of common stock. During fiscal 2024 we repurchased and retired 1,309,635 shares of common stock for $ 53.3 million. During the three months ended March 29, 2025, we repurchased
15
and retired 665,000 shares of common stock for $ 22.1 million, utilizing the remaining shares available for repurchase under the program.
On April 24, 2025, our Board of Directors authorized a new two-year program to repurchase up to $ 75.0 million of outstanding common stock to offset potential dilution from issuance of common stock under our stock-based compensation programs.
Our policy related to repurchases of our common stock is to charge the excess of cost over par value to additional paid-in capital once the shares are retired. Share repurchases are subject to an excise tax enabled by the Inflation Reduction Act that is generally 1% of the fair market value of the shares repurchased at the time of the repurchase, net of the fair market value of certain new stock issuances during the same taxable year. Certain exceptions apply to the excise tax. The excise tax incurred is included in the cost of shares repurchased in the Condensed Consolidated Statement of Stockholders Equity, as applicable. All repurchases were made in compliance with Rule 10b-18 under the Securities Exchange Act of 1934, as amended.
Private Placement
On January 10, 2025, Advantest America, Inc., a Delaware corporation, acquired 334,971 shares of FormFactor's common stock in a private placement for $44.78 per share, representing the 5-day trailing volume-weighted average price prior to signing the related private placement agreement.
Restricted Stock Units
Restricted stock unit (“RSU”) activity under our equity incentive plan was as follows:
Units Weighted Average Grant Date Fair Value
RSUs at December 28, 2024
1,776,743 $ 39.07
Awards granted 10,020 35.73
Awards vested ( 152,278 ) 34.90
Awards forfeited ( 51,875 ) 38.10
RSUs at March 29, 2025
1,582,610 39.68
Performance Restricted Stock Units
We may grant Performance RSUs (“PRSUs”) to certain executives, which vest based upon us achieving certain market performance criteria. There were no PRSUs granted during the three months ended March 29, 2025. PRSUs are included as part of the RSU activity above.
Employee Stock Purchase Plan
Information related to activity under our Employee Stock Purchase Plan (“ESPP”) was as follows:
Three Months Ended
March 29, 2025
Shares issued 197,051
Weighted average per share purchase price $ 33.37
Weighted average per share discount from the fair value of our common stock on the date of issuance $ ( 6.69 )
Stock-Based Compensation
Stock-based compensation was included in our Condensed Consolidated Statements of Income as follows (in thousands):
Three Months Ended
March 29,
2025 March 30,
2024
Cost of revenues $ 2,005 $ 1,928
Research and development 2,646 2,613
Selling, general and administrative 5,145 5,864
Total stock-based compensation $ 9,796 $ 10,405
16
Unrecognized Compensation Costs
At March 29, 2025, the unrecognized stock-based compensation was as follows (dollars in thousands):
Unrecognized
Expense
Average Expected
Recognition Period
in Years
Restricted stock units $ 35,134 1.76
Performance restricted stock units 7,755 1.75
Employee stock purchase plan 1,278 0.34
Total unrecognized stock-based compensation expense $ 44,167 1.72
Note 11 — Net Income per Share
The following table reconciles the shares used in calculating basic net income per share and diluted net income per share (in thousands):
Three Months Ended
March 29,
2025 March 30,
2024
Weighted-average shares used in computing basic net income per share 77,345 77,452
Add potentially dilutive securities 539 1,038
Weighted-average shares used in computing diluted net income per share 77,884 78,490
Securities not included as they would have been antidilutive 593 —
Note 12 — Commitments and Contingencies
Leases
See Note 13, Leases .
Contractual Obligations and Commitments
Our contractual obligations and commitments have not materially changed as of March 29, 2025 from those disclosed in our Annual Report on Form 10-K for the year ended December 28, 2024.
Legal Matters
From time to time, we are subject to legal proceedings and claims in the ordinary course of business, the outcomes of which cannot be estimated with certainty. Our ability to estimate the outcomes may change in the near term and the effect of any such change could have a material adverse effect on our financial position, results of operations or cash flows.
Note 13 — Leases
We lease real estate space under non-cancelable operating lease agreements for commercial and industrial space, as well as for a portion of our corporate headquarters located in Livermore, California. Our leases have remaining terms of one to nine years , and some leases include options to extend up to twenty years . We also have operating leases for automobiles with remaining lease terms of one year . We did not include any of our renewal options in our lease terms for calculating our lease liability as the renewal options allow us to maintain operational flexibility and we are not reasonably certain we will exercise these options at this time. The weighted-average remaining lease term for our operating leases was four years as of March 29, 2025 and the weighted-average discount rate was 4.7 %.
17
The components of lease expense were as follows (in thousands):
Three Months Ended
March 29,
2025 March 30,
2024
Lease expense:
Operating lease expense $ 2,151 $ 2,130
Short-term lease expense 104 60
Variable lease expense 780 810
$ 3,035 $ 3,000
Future minimum payments under our non-cancelable operating leases were as follows as of March 29, 2025 (in thousands):
Fiscal Year Amount
Remainder of 2025
$ 6,834
2026 7,643
2027 7,212
2028 3,902
2029 241
Thereafter 1,161
Total minimum lease payments 26,993
Less: interest ( 2,552 )
Present value of net minimum lease payments
24,441
Less: current portion ( 8,461 )
Total long-term operating lease liabilities
$ 15,980
Note 14 — Revenue
Transaction price allocated to the remaining performance obligations: On March 29, 2025, we had $ 19.4 million of remaining performance obligations, which were comprised of deferred service contracts, extended warranty contracts, and contracts with overtime revenue recognition that are not yet delivered. We expect to recognize approximately 61.2 % of our remaining performance obligations as revenue in the remainder of fiscal 2025, approximately 34.5 % in fiscal 2026, and approximately 4.3 % in fiscal 2027 and thereafter. The foregoing excludes the value of other remaining performance obligations as they have original durations of one year or less, and also excludes information about variable consideration allocated entirely to a wholly unsatisfied performance obligation.
Contract balances: The timing of revenue recognition may differ from the timing of invoicing to customers. Accounts receivable is recorded at the invoiced amount, net of an allowance for credit losses. A receivable is recognized in the period we deliver goods or provide services or when our right to consideration is unconditional. A contract asset is recorded when we have performed under the contract but our right to consideration is conditional on something other than the passage of time. Contract assets as of March 29, 2025 and December 28, 2024 were $ 7.5 million and $ 6.9 million, respectively, and are reported on the Condensed Consolidated Balance Sheets as a component of Prepaid expenses and other current assets.
Contract liabilities include payments received and payments due in advance of performance under a contract and are satisfied as the associated revenue is recognized. Contract liabilities are reported on the Condensed Consolidated Balance Sheets at the end of each reporting period as a component of Deferred revenue and Other liabilities. Contract liabilities as of March 29, 2025 and December 28, 2024 were $ 16.3 million and $ 16.9 million, respectively. During the three months ended March 29, 2025, we recognized $ 8.0 million of revenue that was included in contract liabilities as of December 28, 2024.
Costs to obtain a contract: We generally expense sales commissions when incurred as a component of Selling, general and administrative expense, as the amortization period is typically less than one year.
Revenue by category: Refer to Note 15, Operating Segments and Enterprise-Wide Information , for further details.
18
Note 15 — Operating Segments and Enterprise-Wide Information
We operate in two reportable segments consisting of the Probe Cards segment and the Systems segment.
Our chief operating decision maker (“CODM”) is our President and Chief Executive Officer, who assesses the reportable segments' performance by using each reportable segment's net contribution to make decisions about allocating resources and assessing performance for the entire company. The CODM uses net contribution for each reportable segment predominantly in the annual budget and forecasting process, as well as consideration of budget-to-actual variances on a quarterly basis when making decisions for assessment of our performance and results of operations. Certain components of net contribution are utilized to determine executive compensation along with other measures.
The following table provides net contribution by reportable segment and includes a reconciliation to net income before income taxes (dollars in thousands):
Three Months Ended
March 29, 2025 March 30, 2024
Probe Cards Systems Corporate and Other Total Probe Cards Systems Corporate and Other Total
Revenues $ 136,520 $ 34,836 $ — $ 171,356 $ 136,701 $ 32,024 $ — $ 168,725
Cost of revenues 84,905 19,321 ( 2,607 ) 106,833 85,910 17,518 ( 2,559 ) 105,987
Gross profit 51,615 15,515 ( 2,607 ) 64,523 50,791 14,506 ( 2,559 ) 62,738
Gross margin 37.8 % 44.5 % 37.7 % 37.2 % 45.3 % 37.2 %
Research and development 21,056 3,968 2,776 27,800 20,848 5,166 2,613 28,627
Selling 6,566 3,660 2,801 13,027 7,220 3,586 1,700 12,506
Marketing 1,580 1,741 1,126 4,447 1,918 1,660 1,702 5,280
Net contribution $ 22,413 $ 6,146 $ ( 9,310 ) 19,249 $ 20,805 $ 4,094 $ ( 8,574 ) 16,325
General and administrative 15,980 15,293
Gain on sale of business — 20,271
Operating income 3,269 21,303
Interest income 3,416 3,258
Interest expense ( 99 ) ( 102 )
Other income, net 890 520
Income before income taxes $ 7,476 $ 24,979
Corporate and Other includes unallocated expenses relating to amortization of stock-based compensation expense, intangible assets, acquisition-related costs, including charges related to fixed assets stepped up to fair value, restructuring charges, and other costs, which are not used in evaluating the results of, or in allocating resources to, our reportable segments. Acquisition-related costs include transaction costs and any costs directly related to the acquisition and integration of acquired businesses.
Net contribution represents Operating income excluding general and administrative expenses and gains on sale of business, which are not used in evaluating the results of, or in allocating resources to, our reportable segments.
19
Certain revenue category information by reportable segment was as follows (in thousands):
Three Months Ended
March 29, 2025 March 30, 2024
Probe Cards Systems Total Probe Cards Systems Total
Market:
Foundry & Logic $ 85,272 $ — $ 85,272 $ 86,768 $ — $ 86,768
DRAM 48,858 — 48,858 45,896 — 45,896
Flash 2,390 — 2,390 4,037 — 4,037
Systems — 34,836 34,836 — 32,024 32,024
Total $ 136,520 $ 34,836 $ 171,356 $ 136,701 $ 32,024 $ 168,725
Timing of revenue recognition:
Products transferred at a point in time $ 134,721 $ 31,335 $ 166,056 $ 135,641 $ 28,784 $ 164,425
Products and services transferred over time 1,799 3,501 5,300 1,060 3,240 4,300
Total $ 136,520 $ 34,836 $ 171,356 $ 136,701 $ 32,024 $ 168,725
Geographical region:
Taiwan $ 40,747 $ 4,615 $ 45,362 $ 27,179 $ 2,698 $ 29,877
South Korea 42,209 962 43,171 50,672 45 50,717
United States 27,784 12,541 40,325 35,596 10,170 45,766
China 8,152 5,463 13,615 8,686 6,927 15,613
Japan 5,179 5,140 10,319 4,347 4,195 8,542
Europe 3,535 4,246 7,781 3,528 5,321 8,849
Singapore 4,871 1,378 6,249 3,516 1,242 4,758
Malaysia 2,552 48 2,600 1,608 255 1,863
Rest of World 1,491 443 1,934 1,569 1,171 2,740
Total $ 136,520 $ 34,836 $ 171,356 $ 136,701 $ 32,024 $ 168,725
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.